Exozymes (EXOZ) Total Current Liabilities (2023 - 2024)
Exozymes (EXOZ) has disclosed Total Current Liabilities for 2 consecutive years, with $5.8 million as the latest value for Q3 2024.
- Quarterly Total Current Liabilities changed N/A to $5.8 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Sep 2024, changed N/A year-over-year, with the annual reading at $2.4 million for FY2023, N/A changed from the prior year.
- Total Current Liabilities for Q3 2024 was $5.8 million at Exozymes, up from $2.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $5.8 million in Q3 2024, with the low at $2.4 million in Q4 2023.